Left Menu
Development News Edition

EXCLUSIVE-AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week -sources

The agency is requiring researchers conducting the trial to add information about the incident to consent forms signed by study participants, according to one of the sources. UK regulatory officials previously reviewed the illness and determined there was “insufficient evidence to say for certain” that it was or was not related to the vaccine.

Reuters | Updated: 20-10-2020 22:39 IST | Created: 20-10-2020 22:10 IST
EXCLUSIVE-AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week -sources
Representative image Image Credit: Wikimedia

AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness, four sources told Reuters.

AstraZeneca's large, late-stage U.S. trial has been on hold since Sept. 6, after a participant in the company's UK trial fell ill with what was suspected to be a rare spinal inflammatory disorder called transverse myelitis. The sources, who were briefed on the matter but asked to remain anonymous, said they have been told the trial could resume later this week. It was unclear how the FDA would characterize the illness, they said.

The FDA did not respond to a request for comment. The agency is requiring researchers conducting the trial to add information about the incident to consent forms signed by study participants, according to one of the sources.

UK regulatory officials previously reviewed the illness and determined there was "insufficient evidence to say for certain" that it was or was not related to the vaccine. It permitted the trial to resume enrolling participants in the UK, according to a draft of the updated consent form shared with Reuters. "In this case, after considering the information, the independent reviewers and MHRA (Medicines and Healthcare products Regulatory Agency) recommended that vaccinations should continue," the draft consent form stated. "Close monitoring of the affected individual and other participants will be continued."

Regulators in Brazil, India and South Africa also previously allowed AstraZeneca to resume its vaccine trials there. Responding to a request, British regulators shared with Reuters a draft of a form letter to UK vaccine trial participants, dated Oct. 14 and signed by the Oxford COVID-19 Vaccine Team. It says the U.S. FDA had "completed their analysis" and said vaccination in the United States would resume shortly.

FDA "has come to the same conclusion as the other drug regulators including the MHRA," the letter states. The regulator, Health Research Authority, did not say if the letter had been sent or immediately respond to questions about it. An AstraZeneca spokeswoman said the communication is not from the company and it "cannot verify the content," referring to the draft letter to patients.

"We also cannot comment on a pending FDA decision," she said.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Inadequate water infrastructure causes a tidal wave of coronavirus in rural Alaska

... ...

Videos

Latest News

U.S. prosecutors investigating potential scheme to pay bribe for Trump pardon

The U.S. Justice Department is investigating a potential crime related to funneling money to the White House in exchange for a presidential pardon, according to court documents unsealed in federal court.U.S. District Judge Beryl Howell on T...

Neera Tanden has shown bad judgment in the past: Nikki Haley

Republican politician Nikki Haley Tuesday said Neera Tandens nomination as the Director of Office of Management and Budget is deeply concerning, as she has shown bad judgment in the past. Tanden has shown bad judgment in the past. She said ...

Georgia election official implores Trump to stop fraud rhetoric, fears 'someone's going to get hurt'

A top election official in Georgia on Tuesday implored U.S. President Donald Trump to stop inspiring people to commit potential acts of violence by fanning baseless claims that the election he lost last month was rigged. Gabriel Sterling, m...

GLOBAL MARKETS-Asian stocks rise after vaccine optimism drives Wall St to record highs

Asian markets were set to climb on Wednesday after Wall Street indexes closed at record highs as investors grow increasingly hopeful about a vaccine to combat rising COVID-19 cases and an economic recovery.Weve had some positive leads, and ...

Give Feedback